|
Dr. Cheryl Bartleson directs CellzDirect’s in vitro drug metabolism studies, including cytochrome P450 induction, inhibition and reaction phenotyping studies. Dr. Bartleson received her doctorate in biochemistry from Iowa State University in the laboratory of Dr. Donald J. Graves. Dr. Bartleson’s dissertation focused on the substrate and inhibitor specificities of phosphorylase kinase and protein phosphatase-1. She completed her postdoctoral training at Vanderbilt University School of Medicine. In the Department of Pharmacology with Dr. Hamm’s lab, Dr. Bartleson studied the role of heterotrimeric G proteins in synaptic transmission. Dr. Bartleson continued her post-doctoral studies in the Center in Molecular Toxicology and the Department of Biochemistry. As a research fellow in Dr. Guengerich’s laboratory, Dr. Bartleson studied the expression and tissue-specific localization of the human orphan cytochrome P450s.
| 